Communiqués VolitionRx Limited

Actions

VNRX

US9286611077

Temps Différé Nyse Autres places de cotation 19:09:27 06/06/2024			Varia. 5j.	Varia. 1 janv.
0,6999 ^USD	+2,93 %		+2,75 %	-2,38 %

14/05	Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024
13/05	VolitionRx Limited annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

VolitionRX: Q1 Earnings Snapshot	13/05	AQ
VolitionRX: Q3 Earnings Snapshot	15/11	AQ
Volition and VPG Launch Nu.Q Vet Cancer Test in UK and Ireland	07/11	AQ
VolitionRx Limited Announces Second Quarter 2023 Financial Results and Business Update	15/08/23	AQ
VolitionRX: Q2 Earnings Snapshot	14/08/23	AQ
VolitionRx Limited Schedules Second Quarter 2023 Earnings Conference Call and Business Update	10/08/23	AQ
VolitionRx : Corporate Presentation May 2023	17/05/23	PU
VolitionRX: Q1 Earnings Snapshot	11/05/23	AQ
VolitionRx : Corporate Presentation May 2023	11/05/23	PU
VOLITIONRX LTD : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	10/05/23	AQ
VolitionRx : Corporate Presentation April 2023	25/04/23	PU
VolitionRx : Corporate Presentation March 2023	25/04/23	PU
VOLITIONRX LTD MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	15/03/23	AQ
VolitionRx Limited Schedules Full Year 2022 Earnings Conference Call and Business Update	13/03/23	AQ
VolitionRx Limited to Webcast Live at VirtualInvestorConferences.com March 9th	06/03/23	AQ
VOLITIONRX LTD : Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K)	21/02/23	AQ
VolitionRx Limited Announces Pricing of $7.525 Million Underwritten Public Offering of Common Stock	20/02/23	AQ
Volition's Nu.Q Vet Cancer Test Now Available for Pre-Order at the Point-of-Care Through Heska Corporation	17/02/23	AQ
VolitionRx : Corporate Presentation February 2023	31/01/23	PU
Volition to Take Part in Nu.Q Vet Commercial Strategy Webinar	23/01/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués VolitionRx Limited

Actions

VNRX

US9286611077

Communiqués

Filtres